Cargando…
Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis
The 5-year mortality rates associated with decompensated liver cirrhosis (DLC) can reach 50%, which suggests that this condition poses a serious health risk. In previous studies conducted by our group, autologous bone marrow nucleated cells (ABMNCs) were used to treat HIV-positive patients with DLC...
Autores principales: | Li, Lei, Si, Yanhui, Cheng, Mingrong, Lang, Lin, Li, Aijun, Liu, Baochi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468850/ https://www.ncbi.nlm.nih.gov/pubmed/36160909 http://dx.doi.org/10.3892/etm.2022.11570 |
Ejemplares similares
-
Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus
por: Liu, Baochi, et al.
Publicado: (2021) -
Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy
por: Zhang, Weiwei, et al.
Publicado: (2018) -
Autologous bone marrow cell transplantation in the treatment of HIV patients with compensated cirrhosis
por: Liu, Baochi, et al.
Publicado: (2020) -
Endoscopic ultrasound-guided intraportal injection of autologous bone marrow in patients with decompensated liver cirrhosis: A case series
por: Zheng, Shao-Peng, et al.
Publicado: (2023) -
Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study
por: Liu, Bao-Chi, et al.
Publicado: (2023)